Frequently Asked Questions
Chemotherapy-Induced Peripheral Neuropathy (CIPN), Nerve Health & Prevention
1.What Is Chemotherapy-Induced Peripheral Neuropathy (CIPN)?
What is chemotherapy-induced peripheral neuropathy?
Chemotherapy-induced peripheral neuropathy (CIPN) is damage to the peripheral nerves caused by certain chemotherapy drugs used to treat cancer. These nerves carry messages between the brain, spinal cord, hands, feet, and the rest of the body.
When these nerves are damaged, patients may experience:
Numbness
Tingling
Burning sensations
Pain
Sensitivity to cold or touch
Muscle weakness
Balance problems
Reduced coordination
How common is CIPN?
CIPN is one of the most common side effects of cancer treatment.
Research suggests that:
Approximately 30–70% of patients receiving certain chemotherapy drugs experience some degree of neuropathy.
Symptoms may begin during treatment or appear shortly afterward.
Some patients recover completely, while others may experience symptoms for years.
Which chemotherapy drugs are most commonly associated with CIPN?
The medications most commonly linked to CIPN include:
Taxanes (Paclitaxel, Docetaxel)
Platinum-based drugs (Oxaliplatin, Cisplatin)
Vinca alkaloids (Vincristine)
Bortezomib and related therapies
Not every patient receiving these treatments develops neuropathy, but the risk can be significant.
2.Symptoms & Diagnosis
What are the first signs of neuropathy?
Early symptoms often include:
Tingling in fingers or toes
Numbness
Burning sensations
Increased sensitivity to temperature
Difficulty buttoning clothes
Trouble typing or using a smartphone
Many patients describe the sensation as "pins and needles."
What does neuropathy pain feel like?
People describe neuropathy pain differently.
Common descriptions include:
Electric shocks
Sharp shooting pain
Burning sensations
Stabbing discomfort
Extreme sensitivity to touch
Can neuropathy affect balance and walking?
Yes.
Because peripheral nerves help the body understand position, movement, and pressure, damage can affect:
Balance
Walking
Climbing stairs
Athletic activities
Driving
Many patients report feeling less stable or unsure on uneven surfaces.
How is CIPN diagnosed?
Healthcare providers typically diagnose CIPN using:
Medical history
Physical examination
Neurological testing
Symptom assessments
Functional evaluations
There is currently no single definitive test that diagnoses all cases.
3.How Neuropathy Affects Daily Life
How does neuropathy affect people?
Neuropathy can significantly affect daily activities.
The nerve damage can reduce coordination and increase the risk of injuries because patients may not feel heat, sharp objects, cuts, burns, or infections as easily as before.
Can CIPN affect my ability to work?
Yes.
Depending on severity, neuropathy may affect:
Typing
Writing
Operating machinery
Healthcare work
Skilled trades
Driving
Research has shown that CIPN can impact employment, productivity, and overall quality of life. Nearly one in three people living with CIPN are forced to change jobs.
Can neuropathy become permanent?
Unfortunately, yes.
Some patients recover within months after treatment ends, while others may experience symptoms that persist for years.
The likelihood depends on:
Type of chemotherapy
Total dose received
Individual factors
Existing nerve conditions
4.Prevention & Research
Can chemotherapy-induced neuropathy be prevented?
Currently, there is no universally accepted standard prevention method for CIPN.
However, researchers around the world are studying:
Cooling therapies (cryotherapy)
Compression therapy
Exercise interventions
Neuroprotective medications
Nutritional approaches
What research is happening right now?
Current research focuses on:
Cryotherapy (cooling hands and feet)
Controlled blood-flow restriction techniques
Neuroprotective treatments
Biomarker identification
Personalized prevention strategies
Researchers are working to determine which approaches are safest and most effective.
Why are cooling therapies receiving so much attention?
Several studies suggest that cooling the hands and feet during chemotherapy may help reduce exposure of peripheral nerves to chemotherapy drugs.
Researchers believe cooling may:
Reduce local blood flow
Limit drug delivery to peripheral tissues
Reduce nerve injury
More large-scale clinical studies are still needed.
5.Cooling Therapy & Polar Paws
What is cryotherapy?
Cryotherapy refers to controlled cooling of the hands and feet during chemotherapy infusions.
The goal is to help reduce chemotherapy exposure to peripheral nerves and potentially reduce the risk of nerve damage.
No.
Cooling methods vary widely, and there is currently no universally standardized approach.
This creates an opportunity for innovation and further research.
Is cooling therapy currently standardized?
What is Polar Paws?
Polar Paws is an innovative cooling technology being developed to provide controlled cooling of the hands and feet during chemotherapy.
Polar Paws is intended to automatically regulate skin temperature while cooling the extremities during treatment.
Why is Polar Paws important?
Current cooling solutions may present challenges including:
Inconsistent temperatures
Patient discomfort
Limited accessibility
Lack of standardization
Polar Paws aims to address these challenges through a safer, more controlled approach.
For more information, visit: https://polarpaws.net/
6.Supporting the Foundation
How does my donation help?
Every donation helps advance the Foundation's mission.
Support may contribute to:
Prevention research
Patient education
Public awareness initiatives
Device development
Regulatory pathways
Future patient access programs
The Foundation specifically notes that donations support development and advancement of Polar Paws and efforts to help patients worry less about neuropathy during cancer treatment.
Why focus on prevention instead of treatment?
Once nerve damage occurs, it can be difficult to reverse.
Preventing injury before it happens may:
Improve quality of life
Reduce disability
Support treatment completion
Protect long-term function
Can I support the Foundation if I am not a patient?
Absolutely.
Supporters include:
Family members
Caregivers
Healthcare professionals
Researchers
Community advocates
Corporate sponsors
7.Patient & Caregiver Resources
What should I do if I think I'm developing neuropathy?
Speak with your oncology team immediately.
Early reporting may help:
Monitor progression
Adjust treatment plans if appropriate
Explore supportive care options
Improve safety and quality of life
What questions should I ask my oncologist?
Consider asking:
Am I receiving drugs associated with CIPN?
What symptoms should I watch for?
Should I report symptoms immediately?
Are cooling therapies available?
What research studies are currently enrolling patients?
How can I protect my hands and feet during treatment?
Where can I find trustworthy information?
We recommend these evidence-based organizations: